SG11201703884PA - Treatment of enteral feeding intolerance - Google Patents
Treatment of enteral feeding intoleranceInfo
- Publication number
- SG11201703884PA SG11201703884PA SG11201703884PA SG11201703884PA SG11201703884PA SG 11201703884P A SG11201703884P A SG 11201703884PA SG 11201703884P A SG11201703884P A SG 11201703884PA SG 11201703884P A SG11201703884P A SG 11201703884PA SG 11201703884P A SG11201703884P A SG 11201703884PA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- enteral feeding
- feeding intolerance
- intolerance
- enteral
- Prior art date
Links
- 208000035586 Enteral feeding intolerance Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462078888P | 2014-11-12 | 2014-11-12 | |
| PCT/US2015/060222 WO2016077498A1 (en) | 2014-11-12 | 2015-11-11 | Treatment of enteral feeding intolerance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201703884PA true SG11201703884PA (en) | 2017-06-29 |
Family
ID=55955006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201703884PA SG11201703884PA (en) | 2014-11-12 | 2015-11-11 | Treatment of enteral feeding intolerance |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10092621B2 (ko) |
| EP (1) | EP3217996A4 (ko) |
| JP (1) | JP2017533951A (ko) |
| KR (1) | KR20170085539A (ko) |
| CN (1) | CN107106636A (ko) |
| AU (1) | AU2015346323A1 (ko) |
| CA (1) | CA2967355A1 (ko) |
| EA (1) | EA201791038A1 (ko) |
| IL (1) | IL252234A0 (ko) |
| MX (1) | MX2017006205A (ko) |
| SG (1) | SG11201703884PA (ko) |
| WO (1) | WO2016077498A1 (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20170085539A (ko) | 2014-11-12 | 2017-07-24 | 리릭 파마슈티컬스 인크. | 경장 섭식 불내성의 치료 |
| WO2017197131A1 (en) * | 2016-05-11 | 2017-11-16 | Lyric Pharmaceuticals Inc. | Treatment of enteral feeding intolerance and muscle wasting |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU682894B2 (en) * | 1993-10-28 | 1997-10-23 | Institut National De La Recherche Agronomique | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
| US20090259279A1 (en) | 2002-03-22 | 2009-10-15 | Dobak Iii John D | Splanchnic nerve stimulation for treatment of obesity |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| US7491695B2 (en) | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
| EP2013178A1 (en) | 2006-03-31 | 2009-01-14 | Glaxo Group Limited | Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists |
| US8828953B2 (en) | 2009-04-20 | 2014-09-09 | NaZura BioHealth, Inc. | Chemosensory receptor ligand-based therapies |
| WO2011041369A1 (en) | 2009-09-30 | 2011-04-07 | Tranzyme Pharma, Inc. | Salts, solvates, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same |
| AU2010313282A1 (en) | 2009-10-30 | 2012-05-24 | Ocera Therapeutics, Inc. | Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| US20130261011A1 (en) | 2012-03-30 | 2013-10-03 | Tufts Medical Center, Inc. | Analyzing neonatal saliva and readiness to feed |
| US20130316002A1 (en) | 2012-05-22 | 2013-11-28 | Depomed, Inc. | Compositions and methods for treating gastrointestinal motility dysfunction |
| WO2013175805A1 (en) | 2012-05-25 | 2013-11-28 | Raqualia Pharma Inc. | Ghrelin receptor agonists for the treatment of achlorhydria |
| BR112015009107A2 (pt) | 2012-10-24 | 2017-11-14 | Daiichi Sankyo Co Ltd | agente terapêutico para esclerose lateral amiotrófica, uso de um agonista do receptor do secretagogo do hormônio do crescimento ou um sal farmaceuticamente aceitável do mesmo, e, agonista do receptor do secretagogo do hormônio do crescimento ou sal farmaceuticamente aceitável do mesmo |
| KR20170085539A (ko) | 2014-11-12 | 2017-07-24 | 리릭 파마슈티컬스 인크. | 경장 섭식 불내성의 치료 |
| WO2017083882A1 (en) | 2015-11-11 | 2017-05-18 | Lyric Pharmaceuticals Inc. | Treatment of enteral feeding intolerance and other conditions using ulimorelin analogs |
| WO2017097328A1 (en) | 2015-12-07 | 2017-06-15 | Arcelik Anonim Sirketi | Divider assembly for use in the vegetable drawer of a refrigerator |
| WO2017197131A1 (en) | 2016-05-11 | 2017-11-16 | Lyric Pharmaceuticals Inc. | Treatment of enteral feeding intolerance and muscle wasting |
| WO2017197328A1 (en) | 2016-05-12 | 2017-11-16 | Lyric Pharmaceuticals Inc. | Treatment of enteral feeding intolerance and muscle wasting with relamorelin |
-
2015
- 2015-11-11 KR KR1020177015829A patent/KR20170085539A/ko unknown
- 2015-11-11 EP EP15858484.7A patent/EP3217996A4/en not_active Withdrawn
- 2015-11-11 CN CN201580073216.3A patent/CN107106636A/zh active Pending
- 2015-11-11 EA EA201791038A patent/EA201791038A1/ru unknown
- 2015-11-11 US US15/526,262 patent/US10092621B2/en not_active Expired - Fee Related
- 2015-11-11 SG SG11201703884PA patent/SG11201703884PA/en unknown
- 2015-11-11 WO PCT/US2015/060222 patent/WO2016077498A1/en active Application Filing
- 2015-11-11 MX MX2017006205A patent/MX2017006205A/es unknown
- 2015-11-11 AU AU2015346323A patent/AU2015346323A1/en not_active Abandoned
- 2015-11-11 JP JP2017526590A patent/JP2017533951A/ja active Pending
- 2015-11-11 CA CA2967355A patent/CA2967355A1/en not_active Abandoned
-
2017
- 2017-05-11 IL IL252234A patent/IL252234A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017533951A (ja) | 2017-11-16 |
| US20170304395A1 (en) | 2017-10-26 |
| WO2016077498A1 (en) | 2016-05-19 |
| US10092621B2 (en) | 2018-10-09 |
| CA2967355A1 (en) | 2016-05-19 |
| EP3217996A1 (en) | 2017-09-20 |
| AU2015346323A1 (en) | 2017-06-22 |
| CN107106636A (zh) | 2017-08-29 |
| MX2017006205A (es) | 2017-11-17 |
| IL252234A0 (en) | 2017-07-31 |
| EP3217996A4 (en) | 2018-06-20 |
| KR20170085539A (ko) | 2017-07-24 |
| EA201791038A1 (ru) | 2017-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252839A0 (en) | Treatment of boils | |
| IL250677A0 (en) | Cancer treatment using anti-nkg2a agents | |
| GB201701673D0 (en) | Methods of well treatment | |
| IL289823A (en) | feeding device | |
| IL285003A (en) | Treatment of episode disorders | |
| SG11201609652RA (en) | Treatment of polybacterials infections | |
| GB201401430D0 (en) | Treatment process | |
| HK1231380A1 (zh) | 嚴重高甘油三酯血症的治療 | |
| GB201416832D0 (en) | Methods of treatment | |
| GB201408297D0 (en) | Treatment of cancer | |
| IL252234A0 (en) | Treatment of enteral feeding intolerance | |
| LT3200783T (lt) | Eritromelalgijos gydymas | |
| GB201412010D0 (en) | Treatment of hypertransaminasemia | |
| GB201411027D0 (en) | Treatment | |
| GB201417456D0 (en) | Treatment of cancer | |
| HUE050165T2 (hu) | Etilén-glikolok MMF származékai | |
| GB201412411D0 (en) | Treatment | |
| GB201408752D0 (en) | Arthritis treatment | |
| PL3215171T3 (pl) | Dojelitowa kompozycja odżywcza | |
| GB201417465D0 (en) | Treatment of cancers | |
| GB201409362D0 (en) | Treatment of cancer | |
| GB201405449D0 (en) | Treatment of cancer | |
| GB201405075D0 (en) | Treatment of cancer | |
| GB201413317D0 (en) | Atheroscierosis treatment | |
| GB201412410D0 (en) | Treatment |